Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment

Author:

Durani Urshila1ORCID,Major Ajay2ORCID,Velazquez Ana I.34ORCID,May Jori5ORCID,Nelson Marquita6,Zheng Ze78ORCID,Hall Anurekha G.9,Alam Sara Taveras10ORCID,Reynolds Robby11,Thompson J. Colton11,Kumbamu Ashok12,Das Devika G.5,Murphy Martina C.13,Henry Elizabeth1415ORCID,Lee Alfred Ian16ORCID,Marshall Ariela L.1718ORCID,Wun Ted19ORCID,Weeks Lachelle Dawn20ORCID

Affiliation:

1. Department of Hematology and HCT, City of Hope, Duarte, CA

2. Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL

3. Division of Hematology-Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA

4. National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA

5. Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, AL

6. Division of Hematology and Oncology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN

7. Division of Endocrinology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

8. Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI

9. Division of Hematology and Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA

10. Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX

11. American Society of Hematology, Washington, DC

12. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

13. Division of Hematology and Oncology, University of Florida, Gainesville, FL

14. Department of Medical Education, Loyola University Medical Center, Maywood, IL

15. Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL

16. Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT

17. Division of Hematology, Mayo Clinic, Rochester, MN

18. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

19. Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA

20. Division of Hematologic Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA

Abstract

PURPOSE: Graduate medical and research training has drastically changed during the COVID-19 pandemic, with widespread implementation of virtual learning, redeployment from core rotations to the care of patients with COVID-19, and significant emotional and physical stressors. The specific experience of hematology-oncology (HO) fellows during the COVID-19 pandemic is not known. METHODS: We conducted a mixed-methods study using a survey of Likert-style and open-ended questions to assess the training experience and well-being of HO fellows, including both clinical and postdoctoral trainee members of the American Society of Hematology and ASCO. RESULTS: A total of 2,306 surveys were distributed by e-mail; 548 (23.8%) fellows completed the survey. Nearly 40% of fellows felt that they had not received adequate mental health support during the pandemic, and 22% reported new symptoms of burnout. Pre-existing burnout before the pandemic, COVID-19–related clinical work, and working in a primary research or nonclinical setting were associated with increased burnout on multivariable logistic regression. Qualitative thematic analysis of open-ended responses revealed significant concerns about employment after training completion, perceived variable quality of virtual education and board preparation, loss of clinical opportunities to prepare for independent clinical practice, inadequate grant funding opportunities in part because of shifting research priorities, variable productivity, and mental health or stress during the pandemic. CONCLUSION: HO fellows have been profoundly affected by the pandemic, and our data illustrate multiple avenues for fellowship programs and national organizations to support both clinical and postdoctoral trainees.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology (nursing),Health Policy,Oncology

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3